Emma Smith

1.8k total citations
34 papers, 1.3k citations indexed

About

Emma Smith is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Emma Smith has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Hematology and 7 papers in Immunology. Recurrent topics in Emma Smith's work include Multiple Myeloma Research and Treatments (6 papers), T-cell and B-cell Immunology (6 papers) and Developmental Biology and Gene Regulation (6 papers). Emma Smith is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), T-cell and B-cell Immunology (6 papers) and Developmental Biology and Gene Regulation (6 papers). Emma Smith collaborates with scholars based in United Kingdom, Sweden and United States. Emma Smith's co-authors include Mikael Sigvardsson, Faith E. Davies, Christian Göritz, Zaal Kokaia, Jonas Frisén, David O. Dias, Olle Lindvall, Jens P. Magnusson, Jemal Tatarishvili and Kevin Boyd and has published in prestigious journals such as Science, Journal of Biological Chemistry and Blood.

In The Last Decade

Emma Smith

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Smith United Kingdom 18 705 266 249 247 187 34 1.3k
Konstantin Adamsky Israel 17 681 1.0× 100 0.4× 251 1.0× 124 0.5× 157 0.8× 25 1.3k
Jeff Mann United States 20 1.5k 2.1× 292 1.1× 63 0.3× 227 0.9× 193 1.0× 28 2.2k
Akhilesh Kumar United States 22 893 1.3× 110 0.4× 94 0.4× 155 0.6× 150 0.8× 46 1.4k
Theodore Ho United States 8 784 1.1× 110 0.4× 371 1.5× 299 1.2× 62 0.3× 12 1.5k
Ilaria Visigalli Italy 12 583 0.8× 86 0.3× 77 0.3× 128 0.5× 102 0.5× 17 1.1k
Mayi Arcellana‐Panlilio Canada 16 671 1.0× 337 1.3× 73 0.3× 265 1.1× 97 0.5× 23 1.3k
J D Gearhart United States 25 1.1k 1.6× 68 0.3× 260 1.0× 160 0.6× 100 0.5× 35 2.0k
Antonio Campos‐Caro Spain 23 853 1.2× 68 0.3× 81 0.3× 428 1.7× 81 0.4× 54 1.5k
Mordechai Anafi Canada 13 628 0.9× 46 0.2× 162 0.7× 176 0.7× 199 1.1× 16 1.1k
Minnetta V. Gardinier United States 17 734 1.0× 317 1.2× 37 0.1× 718 2.9× 200 1.1× 24 1.7k

Countries citing papers authored by Emma Smith

Since Specialization
Citations

This map shows the geographic impact of Emma Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Smith more than expected).

Fields of papers citing papers by Emma Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Smith. The network helps show where Emma Smith may publish in the future.

Co-authorship network of co-authors of Emma Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Smith. A scholar is included among the top collaborators of Emma Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Smith. Emma Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leone, Paola, Emma Smith, Cristina Gutiérrez‐Vázquez, et al.. (2025). Oral vancomycin treatment alters levels of indole derivatives and secondary bile acids modulating the expression of mTOR pathway genes in astrocytes during EAE. Brain Behavior and Immunity. 125. 355–370.
2.
Smith, Emma, Paola Leone, Gerold Bongers, et al.. (2023). Oral vancomycin treatment suppresses gut trypsin activity and preserves intestinal barrier function during EAE. iScience. 26(11). 108143–108143. 4 indexed citations
3.
Gigase, Frederieke, Emma Smith, Brett Collins, et al.. (2023). The association between inflammatory markers in blood and cerebrospinal fluid: a systematic review and meta-analysis. Molecular Psychiatry. 28(4). 1502–1515. 28 indexed citations
4.
Wallach, David, Emma Smith, Laura M. Cox, et al.. (2022). Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis. Microbiome. 10(1). 174–174. 45 indexed citations
5.
Dahl, Maria, Emma Smith, Anna Rydström, et al.. (2022). Schlafen2 is a regulator of quiescence in adult murine hematopoietic stem cells. Haematologica. 107(12). 2884–2896. 2 indexed citations
7.
Hansson, Karin, Kristina Aaltonen, Jani Saarela, et al.. (2020). Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma. Science Translational Medicine. 12(562). 22 indexed citations
8.
Dahl, Maria, Emma Smith, Michael Rothe, et al.. (2020). Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector. Molecular Therapy — Methods & Clinical Development. 20. 312–323. 15 indexed citations
9.
Okuyama, Kazuki, Tobias Strid, Rajesh Somasundaram, et al.. (2019). PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia. PLoS Genetics. 15(8). e1008280–e1008280. 33 indexed citations
10.
Mourabit, Sulayman, et al.. (2014). Bmp Suppression in Mangrove Killifish Embryos Causes a Split in the Body Axis. PLoS ONE. 9(1). e84786–e84786. 4 indexed citations
11.
Fryer, Rosemary A, Emma Smith, Simon Walker‐Samuel, et al.. (2013). Characterization of a Novel Mouse Model of Multiple Myeloma and Its Use in Preclinical Therapeutic Assessment. PLoS ONE. 8(2). e57641–e57641. 19 indexed citations
12.
Smith, Emma, Stéphanie Claudinot, Rajwinder Lehal, et al.. (2012). Generation and characterization of a Notch1 signaling‐specific reporter mouse line. genesis. 50(9). 700–710. 13 indexed citations
13.
Moore, Hannah E., Emma L. Davenport, Emma Smith, et al.. (2009). Aminopeptidase inhibition as a targeted treatment strategy in myeloma. Molecular Cancer Therapeutics. 8(4). 762–770. 44 indexed citations
14.
Rolf, Julia, Martin Stenström, Emma Smith, et al.. (2008). Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets. Molecular Immunology. 45(9). 2607–2620. 33 indexed citations
15.
Månsson, Robert, et al.. (2007). The CD53 and CEACAM‐1 genes are genetic targets for early B cell factor. European Journal of Immunology. 37(5). 1365–1376. 9 indexed citations
16.
Månsson, Robert, et al.. (2007). The Cxcl12, Periostin, and Ccl9 Genes Are Direct Targets for Early B-cell Factor in OP-9 Stroma Cells. Journal of Biological Chemistry. 282(19). 14454–14462. 25 indexed citations
17.
Dallman, Margaret J., Emma Smith, Robert A. Benson, & Jonathan R. Lamb. (2005). Notch: control of lymphocyte differentiation in the periphery. Current Opinion in Immunology. 17(3). 259–266. 40 indexed citations
18.
Smith, Emma, Peter Åkerblad, Tom Kadesch, Håkan Axelson, & Mikael Sigvardsson. (2005). Inhibition of EBF function by active Notch signaling reveals a novel regulatory pathway in early B-cell development. Blood. 106(6). 1995–2001. 47 indexed citations
19.
Krotkova, Anna, et al.. (2004). Delayed and Restricted Expression Limits Putative Instructional Opportunities of Vγ1.1/Vγ2 γδ TCR in αβ/γδ Lineage Choice in the Thymus. The Journal of Immunology. 173(1). 25–32. 13 indexed citations
20.
Smith, Emma, Ramiro Gisler, & Mikael Sigvardsson. (2002). Cloning and Characterization of a Promoter Flanking the Early B Cell Factor (EBF) Gene Indicates Roles for E-Proteins and Autoregulation in the Control of EBF Expression. The Journal of Immunology. 169(1). 261–270. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026